Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,511 GBX | +0.03% |
|
-1.21% | +4.19% |
05/07 | GSK: FIRST SINGLE-DOSE MEDICINE TO PREVENT RELAPSE OF P. VIVAX M… | RE |
05/07 | GSK launches antimalarial drug in Thailand and Brazil | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.19% | 7.89TCr | |
+56.89% | 82TCr | |
+39.52% | 63TCr | |
-6.55% | 35TCr | |
+15.99% | 32TCr | |
+7.92% | 30TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.94% | 17TCr |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Transcript : GlaxoSmithKline plc Presents at JPMorgan 34th Annual Healthcare Conference, Jan-12-2016 09